IRadimed Corporation provided earnings guidance for the third quarter of 2022. For the quarter, the company expects to report revenue of $13.1 million to $13.3 million, GAAP diluted earnings per share of $0.21 to $0.24.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.66 USD | -1.12% | -2.24% | -10.33% |
02/05 | Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.33% | 55Cr | |
+75.70% | 1.26TCr | |
-23.45% | 747.43Cr | |
+7.44% | 675.14Cr | |
+11.63% | 549.69Cr | |
-16.58% | 494.49Cr | |
+29.47% | 465.99Cr | |
-25.47% | 375.33Cr | |
-23.01% | 292.09Cr | |
-2.23% | 198.45Cr |
- Stock Market
- Equities
- IRMD Stock
- News IRADIMED CORPORATION
- Iradimed Corporation Provides Earnings Guidance for the Third Quarter of 2022